Transcriptomic Determinants of Response to Pembrolizumab Monotherapy across Solid Tumor Types

Abstract

These findings suggest that features beyond IFNγ-related T-cell inflammation may be relevant to anti-programmed death 1 monotherapy response and may define other axes of tumor biology as candidates for pembrolizumab combinations. See related commentary by Cho et al., p. 1479.